QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep& Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment. Natalie Slivinski This person does ...
Of the handful of parasite species that cause malaria in humans, Plasmodium falciparum is the deadliest. When an infected female Anopheles mosquito feeds on a person, it injects saliva into the ...
Hosted on MSN6mon
Private hospitals report rise in malaria cases in Punea protozoal parasite and a few cases of Plasmodium Falciparum, a unicellular protozoan parasite, said the officials. Dr Ameet Dravid, infectious diseases expert at Noble Hospital, said ...
Ph.D. in Natural Sciences, Georgetown University, Washington D.C. Masters Thesis: 1988 "Detection of antibodies to a defined malarial antigen in humans exposed to Plasmodium falciparum" Ph. D. Thesis: ...
Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 over 90% of them in Africa QIAprep& Plasmodium Kit enables streamlined detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback